Myelogram-Related Arachnoiditis Amendments of 1997
Official title: To amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act with respect to myelogram-related arachnoiditis.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health and Environment.
Myelogram-Related Arachnoiditis Amendments of 1997 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a myelogram involving the use of Pantopaque, Amipaque, Omipacque, or Isovue.
Amends the Public Health Service Act to require a study and research with respect to individuals who have undergone a myelogram and who have subsequently developed arachnoiditis.
- Introduced in House Formatted Text PDF
Cite this page
U.S. Congress. (2026). H.R. 738: Myelogram-Related Arachnoiditis Amendments of 1997. 105th Congress. Open America. https://openamerica.io/bill/105-HR-738/
"H.R. 738: Myelogram-Related Arachnoiditis Amendments of 1997." 105th Congress, 2026, Open America, https://openamerica.io/bill/105-HR-738/.
H.R. 738, 105th Cong. (2026), https://openamerica.io/bill/105-HR-738/.
[H.R. 738: Myelogram-Related Arachnoiditis Amendments of 1997](https://openamerica.io/bill/105-HR-738/)